Actavis

Parsippany Troy Hills, United States Founded: 1956 • Age: 70 yrs Acquired By Teva Pharmaceuticals
Manufacturer of generic products
Request Access

About Actavis

Actavis is a company based in Parsippany Troy Hills (United States) founded in 1956 was acquired by Teva Pharmaceuticals in July 2015.. Actavis has completed 7 acquisitions, including Allergan, Auden Mckenzie and Durata Therapeutics.

  • Headquarter Parsippany Troy Hills, United States
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $8.68 B
    47
    as on Dec 31, 2013
  • Net Profit
    $-725.2 M
    -838
    as on Dec 31, 2013
  • EBITDA
    $-398.8 M
    -226
    as on Dec 31, 2013
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
    Allergan

    & 6 more

  • Acquired by
    Teva Pharmaceuticals

    (Jul 27, 2015)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Actavis

  • Total Funding
  • Total Rounds 1
  • Last Round
  • First Round
  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2014 Amount Debt – Conventional - Actavis Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Actavis

Actavis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Teva Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Actavis

Actavis has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Allergan, Auden Mckenzie and Durata Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Novel antibiotics for infectious diseases are developed by the company.
2009
Drug development for gastroenterology disorders is conducted.
2009
Developer of generic medicines
2001
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Actavis

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Actavis Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Actavis

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Actavis

Frequently Asked Questions about Actavis

When was Actavis founded?

Actavis was founded in 1956 and raised its 1st funding round 58 years after it was founded.

Where is Actavis located?

Actavis is headquartered in Parsippany Troy Hills, United States. It is registered at Parsippany Troy Hills, New Jersey, United States.

What is the annual revenue of Actavis?

Annual revenue of Actavis is $8.68B as on Dec 31, 2013.

What does Actavis do?

Actavis was founded in 1956 and is headquartered in Parsippany Troy Hills, United States. Operations focus on the pharmaceutical sector, with emphasis on generic drug production and distribution. The company acquired Allergan, leading to a name change to Allergan plc, though the U.S. and Canadian generics business continues under the Actavis brand. In 2013, annual revenues reached 5.91 billion, alongside a net profit of 0.09 billion.

How many acquisitions has Actavis made?

Actavis has made 7 acquisitions, including Allergan, Auden Mckenzie, and Durata Therapeutics.

Who are Actavis's investors?

Actavis has 1 investor. Key investors include Teva Pharmaceuticals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available